Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models.

نویسندگان

  • David A M C van de Vijver
  • Brooke E Nichols
  • Ume L Abbas
  • Charles A B Boucher
  • Valentina Cambiano
  • Jeffrey W Eaton
  • Robert Glaubius
  • Katrina Lythgoe
  • John Mellors
  • Andrew Phillips
  • Kim C Sigaloff
  • Timothy B Hallett
چکیده

BACKGROUND Preexposure prophylaxis (PrEP) with tenofovir and emtricitabine can prevent new HIV-1 infections, but there is a concern that use of PrEP could increase HIV drug resistance resulting in loss of treatment options. We compared standardized outcomes from three independent mathematical models simulating the impact of PrEP on HIV transmission and drug resistance in sub-Saharan African countries. METHODS All models assume that people using PrEP receive an HIV test every 3-6 months. The models vary in structure and parameter choices for PrEP coverage, effectiveness of PrEP (at different adherence levels) and the rate with which HIV drug resistance emerges and is transmitted. RESULTS The models predict that the use of PrEP in conjunction with antiretroviral therapy will result in a lower prevalence of HIV than when only antiretroviral therapy is used. With or without PrEP, all models suggest that HIV drug resistance will increase over the next 20 years due to antiretroviral therapy. PrEP will increase the absolute prevalence of drug resistance in the total population by less than 0.5% and amongst infected individuals by at most 7%. Twenty years after the introduction of PrEP, the majority of drug-resistant infections is due to antiretroviral therapy (50-63% across models), whereas 40-50% will be due to transmission of drug resistance, and less than 4% to the use of PrEP. CONCLUSION HIV drug resistance resulting from antiretroviral therapy is predicted to far exceed that resulting from PrEP. Concern over drug resistance should not be a reason to limit the use of PrEP.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

HIV treatment, preexposure prophylaxis, and drug resistance: reconciling conflicting predictions from mathematical models.

TO THE EDITOR—We read with interest the article by Abbas et al, in which they model the potential impact of preexposure prophylaxis (PrEP) on human immunodeficiency virus (HIV) transmission and drug resistance in South Africa [1]. They predict that rolling out Truvadabased PrEP will increase the transmission and prevalence of resistance. Notably, their results conflict with those from 2 previou...

متن کامل

Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe.

BACKGROUND Preexposure prophylaxis (PrEP) with antiretroviral drugs may prevent transmission of human immunodeficiency virus (HIV). Our objective was to predict whether PrEP, in the presence of circulating drug resistance, will reduce the risk of infection with HIV. METHODS We used risk equations to calculate the monthly risk of infection with HIV before and after the introduction of PrEP. Un...

متن کامل

Is the Role of Physicians Really Evolving Due to Non-physician Clinicians Predominance in Staff Makeup in Sub-Saharan African Health Systems?; Comment on “Non-physician Clinicians in Sub-Saharan Africa and the Evolving Role of Physicians”

Health workforce shortages in Sub-Saharan Africa are widely recognized, particularly of physicians, leading the training and deployment of Non-physician clinicians (NPCs). The paper by Eyal et al provides interesting and legitimate viewpoints on evolving role of physicians in context of decisive increase of NPCss in Sub-Saharan Africa. Certainly, in short or mid-term, NPCs will continue to be a...

متن کامل

Non-physician Clinicians – A Gain for Physicians’ Working in Sub-Saharan Africa; Comment on “Non-physician Clinicians in Sub-Saharan Africa and the Evolving Role of Physicians”

The changing demands on the health sectors in low- and middle-income countries especially sub-Saharan African countries continue to challenge efforts to address critical shortages of the health workforce. Addressing these challenges have led to the evolution of “non-physician clinicians” (NPCs), that assume some physician roles and thus mitigate the continuing shortage of doctors in these count...

متن کامل

HIV-1 drug resistance resulting from antiretroviral therapy far exceeds that from pre-exposure prophylaxis.

TO THE EDITOR—We challenge the conclusions drawn by Hurt et al in their Viewpoint article " Pre-exposure Prophy-laxis and Antiretroviral Resistance: HIV Prevention at a Cost? " The authors cite the very few cases of human immunode-ficiency virus (HIV) drug resistance that have occurred in seroconverters from trials of pre-exposure prophylaxis (PrEP) as evidence of the potential for PrEP to jeop...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • AIDS

دوره 27 18  شماره 

صفحات  -

تاریخ انتشار 2013